20 research outputs found

    Equilibrium, kinetic and thermodynamic of direct blue 86 dye adsorption on activated carbon obtained from manioc husk

    Get PDF
    Objective. To establish by means of experimenting by batch the capacity of removal, the kinetics and adsorption thermodynamics of activated carbon prepared from manioc husk (Manihot esculenta) in the removal of direct blue 86 dye. Materials and methods. Firstly, the experimental methodology worked on the preparation of activated carbon by chemical activation of manioc husk with H3PO4 calcined at 530°C. In the characterization the texture properties were determined by means of the blue methylene and iodine indices, the basic and acidic functional groups were quantified by the Boehm method, and the proximate analyses were done following the norms ASTM D2867-70, ASTM D2866 and ASTM D2866-94. During the batch studies, the effect of several parameters over the adsorption capacity was evaluated: pH (2, 4, 8 and 10), temperature (25, 30 and 40°C) and initial concentration of the dye (20, 40, 60, 80 and 100 mg/L). Both physicochemical and adsorption characteristics of the activated carbon from manioc husk (CAY) were compared against those of a commercial brand (CAM). Results. The results of characterization showed that both carbons have a chemistry heterogeneous surface, acidic for CAY and basic for CAM. The maximum capacity obtained was 6.1 mg/g for CAY and 3.7 mg/g for CAM. The thermodynamic calculations showed that the removal was spontaneous. The kinetics for both carbon samples fits a pseudo second-order model. Conclusions. The activated carbon obtained from the manioc husk can be considered an efficient adsorbent for the removal of dye

    Equilibrio, cinética y termodinámica de la adsorción del colorante DB-86 sobre carbón activado de la cáscara de yuca

    No full text
    ABSTRACT Objective. To establish by means of experimenting by batch the capacity of removal, the kinetics and adsorption thermodynamics of activated carbon prepared from manioc husk (Manihot esculenta) in the removal of direct blue 86 dye. Materials and methods. Firstly, the experimental methodology worked on the preparation of activated carbon by chemical activation of manioc husk with H3PO4 calcined at 530°C. In the characterization the texture properties were determined by means of the blue methylene and iodine indices, the basic and acidic functional groups were quantified by the Boehm method, and the proximate analyses were done following the norms ASTM D2867-70, ASTM D2866 and ASTM D2866-94. During the batch studies, the effect of several parameters over the adsorption capacity was evaluated: pH (2, 4, 8 and 10), temperature (25, 30 and 40°C) and initial concentration of the dye (20, 40, 60, 80 and 100 mg/L). Both physicochemical and adsorption characteristics of the activated carbon from manioc husk (CAY) were compared against those of a commercial brand (CAM). Results. The results of characterization showed that both carbons have a chemistry heterogeneous surface, acidic for CAY and basic for CAM. The maximum capacity obtained was 6.1 mg/g for CAY and 3.7 mg/g for CAM. The thermodynamic calculations showed that the removal was spontaneous. The kinetics for both carbon samples fits a pseudo second-order model. Conclusions. The activated carbon obtained from the manioc husk can be considered an efficient adsorbent for the removal of dyes.RESUMEN Objetivo. Establecer mediante experimentos por lote la capacidad de remoción, la cinética y termodinámica de adsorción del carbón activado preparado a partir de la cáscara de yuca (Manihot esculenta) en la remoción del colorante azul directo 86. Materiales y métodos. La metodología experimental consistió inicialmente en la preparación del carbón activado por activación química de la cáscara de yuca con H3PO4 y su posterior calcinación a 530°C. En la caracterización se determinaron las propiedades de textura mediante el índice de yodo e índice de azul de metileno, se cuantificaron los grupos funcionales orgánicos ácidos y básicos con el método Boehm, y se realizó el análisis próximo siguiendo las normas ASTM D-2867-70, ASTM D2866 y ASTM D2866-94. En el estudio por lote, el efecto de varios parámetros sobre la capacidad de adsorción fueron evaluados: el pH (2, 4, 8 y 10), la temperatura (25, 30 y 40°C) y la concentración inicial de colorante (20, 40, 60, 80 y 100 mg/L). Tanto las características fisicoquímicas como los ensayos de adsorción del carbón activado preparado a partir de la cáscara de yuca (CAY) fueron comparadas con otro de marca comercial (CAM). Resultados. Los resultados de la caracterización indican que ambos carbones tienen una química de superfície heterogénea, de naturaleza ácida para el CAY y básica para el CAM. La máxima capacidad obtenida fue 6.1 mg/g para el CAY y de 3.7 mg/g para el CAM. Los cálculos termodinámicos indican que la remoción es espontánea y para ambos carbones la cinética se ajusta al modelo de pseudo segundo orden. Conclusiones. El carbón activado obtenido a partir de la cáscara de yuca puede considerarse un adsorbente eficiente en la remoción de colorantes

    MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models.

    No full text
    Activation of the mitogen-activated protein kinase (MAPK) pathway is frequent in cancer. Drug development efforts have been focused on kinases in this pathway, most notably on RAF and MEK. We show here that MEK inhibition activates JNK-JUN signaling through suppression of DUSP4, leading to activation of HER Receptor Tyrosine Kinases. This stimulates the MAPK pathway in the presence of drug, thereby blunting the effect of MEK inhibition. Cancers that have lost MAP3K1 or MAP2K4 fail to activate JNK-JUN. Consequently, loss-of-function mutations in either MAP3K1 or MAP2K4 confer sensitivity to MEK inhibition by disabling JNK-JUN-mediated feedback loop upon MEK inhibition. In a panel of 168 Patient Derived Xenograft (PDX) tumors, MAP3K1 and MAP2K4 mutation status is a strong predictor of response to MEK inhibition. Our findings suggest that cancers having mutations in MAP3K1 or MAP2K4, which are frequent in tumors of breast, prostate and colon, may respond to MEK inhibitors. Our findings also suggest that MAP3K1 and MAP2K4 are potential drug targets in combination with MEK inhibitors, in spite of the fact that they are encoded by tumor suppressor genes

    Charged-pion cross sections and double-helicity asymmetries in polarized p plus p collisions at root s=200 GeV

    No full text
    We present midrapidity charged-pion invariant cross sections, the ratio of the pi(-) to pi(+) cross sections and the charge-separated double-spin asymmetries in polarized p + p collisions at root s = p + 200 GeV. While the cross section measurements are consistent within the errors of next-to-leading-order (NLO) perturbative quantum chromodynamics predictions (pQCD), the same calculations overestimate the ratio of the charged-pion cross sections. This discrepancy arises from the cancellation of the substantial systematic errors associated with the NLO-pQCD predictions in the ratio and highlights the constraints these data will place on flavor-dependent pion fragmentation functions. The charge-separated pion asymmetries presented here sample an x range of similar to 0.03-0.16 and provide unique information on the sign of the gluon-helicity distribution

    Evolution of pi(0) Suppression in Au plus Au Collisions from root s(NN)=39 to 200 GeV

    Get PDF
    Neutral-pion pi(0) spectra were measured at midrapidity (vertical bar y vertical bar < 0.35) in Au + Au collisions at root s(NN) = 39 and 62.4 GeV and compared with earlier measurements at 200 GeV in a transverse-momentum range of 1 < p(T) < 10 GeV/c. The high-p(T) tail is well described by a power law in all cases, and the powers decrease significantly with decreasing center-of-mass energy. The change of powers is very similar to that observed in the corresponding spectra for p + p collisions. The nuclear modification factors (RAA) show significant suppression, with a distinct energy, centrality, and p(T) dependence. Above p(T) = 7 GeV/c, R-AA is similar for root sNN = 62.4 and 200 GeV at all centralities. Perturbative-quantum-chromodynamics calculations that describe R-AA well at 200 GeV fail to describe the 39 GeV data, raising the possibility that, for the same p(T) region, the relative importance of initial-state effects and soft processes increases at lower energies. The p(T) range where pi(0) spectra in central Au + Au collisions have the same power as in p + p collisions is approximate to 5 and 7 GeV/c for root sNN = 200 and 62.4 GeV, respectively. For the root sNN = 39 GeV data, it is not clear whether such a region is reached, and the x(T) dependence of the x(T)-scaling power-law exponent is very different from that observed in the root sNN = 62 and 200 GeV data, providing further evidence that initial-state effects and soft processes mask the in-medium suppression of hardscattered partons to higher p(T) as the collision energy decreases

    Low-mass vector-meson production at forward rapidity in p plus p collisions at root s=200 GeV

    No full text
    The PHENIX experiment at the Relativistic Heavy Ion Collider has measured low-mass vector-meson ,omega, rho, and phi, production through the dimuon decay channel at forward rapidity (1.2 mu mu) = 80 +/- 6(stat) +/- 12(syst)nb and d sigma/dy(phi -> mu mu) = 27 +/- 3(stat) +/- 4(syst)nb. These results are compared with midrapidity measurements and calculations

    Therapeutic strategies targeting connexins

    No full text
    The connexin family of channel-forming proteins is present in every tissue type in the human anatomy. Connexins are best known for forming clustered intercellular channels, structurally known as gap junctions, where they serve to exchange members of the metabolome between adjacent cells. In their single-membrane hemichannel form, connexins can act as conduits for the passage of small molecules in autocrine and paracrine signalling. Here, we review the roles of connexins in health and disease, focusing on the potential of connexins as therapeutic targets in acquired and inherited diseases as well as wound repair, while highlighting the associated clinical challenges

    Therapeutic strategies targeting connexins

    No full text
    corecore